Skip to main content
    I

    In8bio Inc (INAB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.82
    -0.00 (-0.49%)

    Market Cap: $8.86M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(11/23)
    Avg Surprise
    +3.52%
    Streak
    6 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.36
    Range-$0.64 - -$0.18
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.33
    Range-$0.33 - -$0.33
    1 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago-$0.39+15.4%
    30d ago-$0.39+15.4%
    7d ago-$0.39+15.4%
    Current-$0.33
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-141.80%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio5.78xQuick Ratio5.78x
    Trading Statistics
    Beta0.24Avg Volume272.75K
    52-Week High$2.7352-Week Low$0.80

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 25.5% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 34.7, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.88
    SMA 20$0.94
    SMA 50$1.10
    SMA 200$1.38
    EMA 10$0.88
    EMA 20$0.94
    EMA 50$1.05
    EMA 200$1.40

    MACD

    Line: -0.08Signal: -0.08Hist: -0.01

    ADX

    ADX: 41.0+DI: 10.5-DI: 35.1

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$0.99

    Bollinger Bands

    Upper Band$1.12
    Lower Band$0.76
    %B Position3792%(Upper)
    Band Width0.15

    RSI (14-Day)

    Neutral
    34.7

    Momentum Oscillators

    Stoch %K14.8
    Stoch %D17.2
    Williams %R-71.7
    ROC (10d)-10.3%
    Momentum-0.09
    CCI (20d)-136.6
    MFI (14d)3.1

    Volatility Measures

    ATR (14d)$0.10(11.7%)
    StdDev (20d)0.09
    Hist Vol94.1%(High)

    Volume Flow

    VWAP$0.82
    OBV-83.6M
    AD Line55.8B
    CMF (20d)-0.150

    Volume Metrics

    Avg Vol (20d)285.3K
    Vol Ratio17.7x(High)
    VWMA (20d)$0.83

    Pivot Points

    R3$0.93
    R2$0.91
    R1$0.87
    Pivot Point$0.84
    S1$0.80
    S2$0.77
    S3$0.73

    Advanced Oscillators

    TSI-25.98
    Ultimate Osc30.7
    KST-231.41

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about INAB

    News

    INAB Valuation

    GNG's valuation label for INAB is Undervalued.

    P/B
    1.1x
    All INAB metrics

    INAB Profitability: Margins, ROIC and FCF

    In8bio (INAB) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -141.8%
    INAB financial statements

    The companies most similar to In8bio (INAB) include GT Biopharma, Intensity Therapeutics, Inc. Common stock and Exicure.

    Sector: Healthcare

    Companies most similar to In8bio

    INAB Analyst Ratings

    In8bio (INAB) has a Buy consensus from 3 analysts: 3 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    1
    Buy
    2
    Hold
    0
    Sell
    0
    Strong Sell
    0
    INAB stock forecast

    INAB Bull Case vs Bear Case

    Bull case

    • INAB beat EPS estimates in 75.0% of its last 8 reported quarters.

    INAB Earnings: Beat Rate and Next Report

    In8bio (INAB) beat the EPS estimate in 6 of the last 8 quarters (75.0%). Its next report is expected on Mar 10, 2027.

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    26.8%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.36
    INAB earnings history

    INAB Earnings Date

    INAB reports Mar 10, 2027. The date is estimated.

    INAB ETF Holders

    See insider activity

    Updated Nov 5, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About INAB

    When does INAB report earnings?

    In8bio Inc (INAB) is expected to report earnings on Mar 10, 2027.

    Does INAB pay dividends?

    In8bio Inc (INAB) does not currently pay a regular dividend.

    What is INAB's market cap?

    In8bio Inc (INAB) has a market capitalization of $8.86M with a current stock price of $0.82.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.